For instance, in 2020, according to the International Society of Aesthetic Plastic Surgery (ISAPS) global survey, there were 14,400,347 nonsurgical procedures performed worldwide.
Increasing Demand for Non-Invasive Cosmetic Procedures
The increasing demand for non-invasive cosmetic procedures is one of the major factors driving the growth of the global carboxy therapy market.
Growing Awareness about Benefits of Carboxy Therapy
Growing awareness about the benefits of carboxy therapy is a major factor influencing the growth of the global carboxy therapy market.
Download Free Sample ReportRising Prevalence of Skin-Related Conditions
The rising prevalence of skin-related conditions is a significant factor influencing the growth of the global carboxy therapy market.
Technological Advancements
Technological advancements are a significant factor influencing the growth of the global carboxy therapy market.
Increasing Number of Healthcare Facilities Offering Carboxy Therapy
The increasing number of healthcare facilities offering carboxy therapy is a significant factor influencing the growth of the global carboxy therapy market.
Recent Developments
- In March 2021, Air Liquidesigned an agreement with the Gippsland Basin Joint Venture, a 50-50 jointVenture between BHP Petroleum Pty Ltd and Esso Australia Resources Pty Ltd forthe construction of a new facility to distribute carbon dioxide to Australianindustries. This facility will be built next to the Longford Gas ConditioningPlant, owned by Gippsland Basin Joint Venture and operated by Esso Australiawhich will capture CO2 from its operations and deliver it to Air Liquide forpurification and reuse.
- In March 2019, Air Productsacquired ACP Europe SA, one of the largest independent carbon dioxidesproducing companies in Europe. The acquisition will help the company serve itscustomers efficiently and boost growth opportunities across additional Europeancountries.
- In January 2020, Cosmo ProLtd launched DIOX carboxy therapy system. The DIOX system features a touchscreen interface and both automatic and manual modes.
Market Segmentation
Global Carboxy Therapy market can be segmented by type, application, end users and by region. Based on the type, the market can be segmented into Tabletop, Portable, Others. Based on application, the market can be segmented into Tabletop, Portable, Others. Based on end users, the market can be differentiated into Hospitals, Aesthetic Clinics, Wellness Centers.
Market Players
DTA Medical.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | By Type By Application By End Users By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled | DTA Medical., Fosun Pharmaceutical Co., Ltd., Merz Pharma GmbH & Co. KGaA., Cosmo Pro Ltd., Allergan plc., Carbossiterapia Italiana., Beijing Jontelaser Technologies Co. Ltd., Kastner-Praxisbedarf., Mezopharma., MBE Medical Division., Nick Fanavaran Plasma Company., Alvi Prague., and JONTE. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |